Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Reynolds

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|June 10, 2017
Rapid Vision Correction by Special Operations ForcesMark E Reynolds
MSMR|September 27, 2019
Editorial: The Department of Defense/Veterans Affairs Vision Center of ExcellenceMark E Reynolds
Ophthalmic Epidemiology|December 21, 2022
Trend of Incidence of Ocular Injury in Service Members of the U.S. Armed Forces in 2016-2019Mark E Reynolds, Weidong Gu
JAMA|April 7, 2018
The Risks to Patient Safety From Health System ExpansionsSusan Haas, Atul Gawande, Mark E Reynolds
MSMR|September 27, 2019
Incidence and prevalence of selected refractive errors, active component, U.S. Armed Forces, 2001-2018Mark E Reynolds, Stephen B Taubman, Shauna Stahlman
MSMR|September 27, 2019
Incident and recurrent cases of central serous chorioretinopathy, active component, U.S. Armed Forces, 2001-2018Mark E Reynolds, James W Karesh, Gi-Taik Oh, et al.
MSMR|September 27, 2019
Absolute and relative morbidity burdens attributable to ocular and vision-related conditions, active component, U.S. Armed Forces, 2018Mark E Reynolds, Valerie F Williams, Stephen B Taubman, et al.
MSMR|September 27, 2019
Incidence and temporal presentation of visual dysfunction following diagnosis of traumatic brain injury, active component, U.S. Armed Forces, 2006-2017Mark E Reynolds, Felix M Barker, Natalya Merezhinskaya, et al.
MSMR|February 6, 2020
Brief report: Incidence and prevalence of idiopathic corneal ectasias, active component, 2001-2018Mark E Reynolds, Andrew S Morgenstern, Rita K Mallia, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2002
Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptorGerald R Nakamura, Mark E Reynolds, Yvonne M Chen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|June 10, 2017
Rapid Vision Correction by Special Operations ForcesMark E Reynolds
MSMR|September 27, 2019
Editorial: The Department of Defense/Veterans Affairs Vision Center of ExcellenceMark E Reynolds
Ophthalmic Epidemiology|December 21, 2022
Trend of Incidence of Ocular Injury in Service Members of the U.S. Armed Forces in 2016-2019Mark E Reynolds, Weidong Gu
JAMA|April 7, 2018
The Risks to Patient Safety From Health System ExpansionsSusan Haas, Atul Gawande, Mark E Reynolds
MSMR|September 27, 2019
Incidence and prevalence of selected refractive errors, active component, U.S. Armed Forces, 2001-2018Mark E Reynolds, Stephen B Taubman, Shauna Stahlman
MSMR|September 27, 2019
Incident and recurrent cases of central serous chorioretinopathy, active component, U.S. Armed Forces, 2001-2018Mark E Reynolds, James W Karesh, Gi-Taik Oh, et al.
MSMR|September 27, 2019
Absolute and relative morbidity burdens attributable to ocular and vision-related conditions, active component, U.S. Armed Forces, 2018Mark E Reynolds, Valerie F Williams, Stephen B Taubman, et al.
MSMR|September 27, 2019
Incidence and temporal presentation of visual dysfunction following diagnosis of traumatic brain injury, active component, U.S. Armed Forces, 2006-2017Mark E Reynolds, Felix M Barker, Natalya Merezhinskaya, et al.
MSMR|February 6, 2020
Brief report: Incidence and prevalence of idiopathic corneal ectasias, active component, 2001-2018Mark E Reynolds, Andrew S Morgenstern, Rita K Mallia, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2002
Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptorGerald R Nakamura, Mark E Reynolds, Yvonne M Chen, et al.
Pageof 2